Carmen Belmonte

606 total citations
21 papers, 455 citations indexed

About

Carmen Belmonte is a scholar working on Pharmacology, Pediatrics, Perinatology and Child Health and Oncology. According to data from OpenAlex, Carmen Belmonte has authored 21 papers receiving a total of 455 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 6 papers in Pediatrics, Perinatology and Child Health and 6 papers in Oncology. Recurrent topics in Carmen Belmonte's work include Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Carmen Belmonte is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Drug Transport and Resistance Mechanisms (6 papers) and Pharmacological Effects and Toxicity Studies (5 papers). Carmen Belmonte collaborates with scholars based in Spain, United States and Poland. Carmen Belmonte's co-authors include Francisco Abad‐Santos, Dolores Ochoa, Manuel Román, Miriam Saiz‐Rodríguez, Dóra Koller, Pablo Zubiaur, Aneta Wojnicz, Gina Mejía‐Abril, María Talegón and Teresa Cabaleiro and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Journal of Pharmaceutical and Biomedical Analysis and Clinical Therapeutics.

In The Last Decade

Carmen Belmonte

21 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carmen Belmonte Spain 14 188 118 111 84 66 21 455
Gina Mejía‐Abril Spain 15 259 1.4× 105 0.9× 128 1.2× 108 1.3× 69 1.0× 49 647
Arne Risselada Netherlands 14 132 0.7× 145 1.2× 75 0.7× 41 0.5× 68 1.0× 29 573
Ingrid Fricke-Galindo Mexico 14 181 1.0× 98 0.8× 145 1.3× 130 1.5× 127 1.9× 41 720
M.E.G. Naranjo Spain 10 305 1.6× 42 0.4× 76 0.7× 114 1.4× 67 1.0× 12 425
Pablo Zubiaur Spain 17 332 1.8× 171 1.4× 164 1.5× 130 1.5× 97 1.5× 73 877
Marcos Navares‐Gómez Spain 12 171 0.9× 53 0.4× 73 0.7× 64 0.8× 49 0.7× 35 361
Tamara Božina Croatia 12 75 0.4× 67 0.6× 74 0.7× 65 0.8× 30 0.5× 34 312
Muradiye Nacak Türkiye 13 203 1.1× 36 0.3× 81 0.7× 103 1.2× 94 1.4× 29 598
Yaowaluck Hongkaew Thailand 15 147 0.8× 202 1.7× 173 1.6× 37 0.4× 80 1.2× 27 515
Katalin Tóth Hungary 15 123 0.7× 145 1.2× 143 1.3× 112 1.3× 42 0.6× 44 540

Countries citing papers authored by Carmen Belmonte

Since Specialization
Citations

This map shows the geographic impact of Carmen Belmonte's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carmen Belmonte with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carmen Belmonte more than expected).

Fields of papers citing papers by Carmen Belmonte

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carmen Belmonte. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carmen Belmonte. The network helps show where Carmen Belmonte may publish in the future.

Co-authorship network of co-authors of Carmen Belmonte

This figure shows the co-authorship network connecting the top 25 collaborators of Carmen Belmonte. A scholar is included among the top collaborators of Carmen Belmonte based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carmen Belmonte. Carmen Belmonte is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ochoa, Dolores, Manuel Román, Carmen Belmonte, et al.. (2021). Pharmacokinetics and Safety of a Bilastine Once-Daily, Preservative-Free, Ophthalmic Formulation. Advances in Therapy. 38(7). 4070–4081. 6 indexed citations
2.
Saiz‐Rodríguez, Miriam, Carmen Belmonte, José Luis Caniego, et al.. (2019). Influence of CYP450 Enzymes, CES1, PON1, ABCB1, and P2RY12 Polymorphisms on Clopidogrel Response in Patients Subjected to a Percutaneous Neurointervention. Clinical Therapeutics. 41(6). 1199–1212.e2. 24 indexed citations
3.
Zubiaur, Pablo, Miriam Saiz‐Rodríguez, Dolores Ochoa, et al.. (2019). Influence of CYP2B6 activity score on the pharmacokinetics and safety of single dose efavirenz in healthy volunteers. The Pharmacogenomics Journal. 20(2). 235–245. 13 indexed citations
4.
Koller, Dóra, Carmen Belmonte, Miriam Saiz‐Rodríguez, et al.. (2019). Effects of aripiprazole on circadian prolactin secretion related to pharmacogenetics in healthy volunteers. Basic & Clinical Pharmacology & Toxicology. 126(3). 236–246. 10 indexed citations
5.
Saiz‐Rodríguez, Miriam, Dolores Ochoa, Carmen Belmonte, et al.. (2019). Polymorphisms in CYP1A2, CYP2C9 and ABCB1 affect agomelatine pharmacokinetics. Journal of Psychopharmacology. 33(4). 522–531. 37 indexed citations
6.
Saiz‐Rodríguez, Miriam, Dolores Ochoa, Carmen Belmonte, et al.. (2018). Polymorphisms associated with fentanyl pharmacokinetics, pharmacodynamics and adverse effects. Basic & Clinical Pharmacology & Toxicology. 124(3). 321–329. 45 indexed citations
7.
Saiz‐Rodríguez, Miriam, Carmen Belmonte, Manuel Román, et al.. (2018). Effect of ABCB1 C3435T Polymorphism on Pharmacokinetics of Antipsychotics and Antidepressants. Basic & Clinical Pharmacology & Toxicology. 123(4). 474–485. 52 indexed citations
8.
Koller, Dóra, Carmen Belmonte, Rubin Lubomirov, et al.. (2018). Effects of aripiprazole on pupillometric parameters related to pharmacokinetics and pharmacogenetics after single oral administration to healthy subjects. Journal of Psychopharmacology. 32(11). 1212–1222. 13 indexed citations
9.
Belmonte, Carmen, Dolores Ochoa, Manuel Román, et al.. (2018). Influence of CYP2D6,CYP3A4,CYP3A5 and ABCB1 Polymorphisms on Pharmacokinetics and Safety of Aripiprazole in Healthy Volunteers. Basic & Clinical Pharmacology & Toxicology. 122(6). 596–605. 66 indexed citations
10.
Saiz‐Rodríguez, Miriam, José Luis Caniego, Carmen Belmonte, et al.. (2018). Influence of CYP2C19 Phenotype on the Effect of Clopidogrel in Patients Undergoing a Percutaneous Neurointervention Procedure. Clinical Pharmacology & Therapeutics. 105(3). 661–671. 15 indexed citations
11.
Saiz‐Rodríguez, Miriam, et al.. (2018). Influence of thiopurine S‐methyltransferase polymorphisms in mercaptopurine pharmacokinetics in healthy volunteers. Basic & Clinical Pharmacology & Toxicology. 124(4). 449–455. 7 indexed citations
12.
Saiz‐Rodríguez, Miriam, Carmen Belmonte, Nieves Derqui, et al.. (2017). Pharmacogenetics of Trazodone in Healthy Volunteers: Association with Pharmacokinetics, Pharmacodynamics and Safety. Pharmacogenomics. 18(16). 1491–1502. 14 indexed citations
13.
Wojnicz, Aneta, Carmen Belmonte, Dóra Koller, et al.. (2017). Effective phospholipids removing microelution-solid phase extraction LC-MS/MS method for simultaneous plasma quantification of aripiprazole and dehydro-aripiprazole: Application to human pharmacokinetic studies. Journal of Pharmaceutical and Biomedical Analysis. 151. 116–125. 27 indexed citations
14.
Saiz‐Rodríguez, Miriam, Carmen Belmonte, Manuel Román, et al.. (2017). Effect of Polymorphisms on the Pharmacokinetics, Pharmacodynamics and Safety of Sertraline in Healthy Volunteers. Basic & Clinical Pharmacology & Toxicology. 122(5). 501–511. 52 indexed citations
15.
Belmonte, Carmen, Manuel Román, Miriam Saiz‐Rodríguez, et al.. (2017). Influence of CYP2D6 , CYP3A4 , CYP3A5 and abcb1 Polymorphisms in Pharmacokinetics and Safety of Ariprazole in Healthy Volunteers. Clinical Therapeutics. 39(8). e54–e55. 2 indexed citations
16.
Saiz‐Rodríguez, Miriam, Carmen Belmonte, Teresa Cabaleiro, et al.. (2017). ABCB1 C3435T Polymorphism Affects In Different Ways The Pharmacokinetics of Antipsychotics and Antidepressants. Clinical Therapeutics. 39(8). e36–e36. 2 indexed citations
17.
Ovejero‐Benito, María C., Rocío Prieto‐Pérez, Mar Llamas‐Velasco, et al.. (2017). Polymorphisms Associated with Etanercept Response in Moderate-To-Severe Plaque Psoriasis. Pharmacogenomics. 18(7). 631–638. 24 indexed citations
18.
Belmonte, Carmen. (2016). Biografia di un dipinto. La Battaglia di Dogali di Michele Cammarano tra retorica coloniale e sfortuna espositiva. Persée (Ministère de lEnseignement supérieur et de la Recherche). 13(1). 284–299. 2 indexed citations
19.
Belmonte, Carmen, Dolores Ochoa, Manuel Román, et al.. (2016). Evaluation of the Relationship Between Pharmacokinetics and the Safety of Aripiprazole and Its Cardiovascular Effects in Healthy Volunteers. Journal of Clinical Psychopharmacology. 36(6). 608–614. 14 indexed citations
20.
Belmonte, Carmen, et al.. (2008). Mosaic glass made in Rome between the sixteenth and seventeenth centuries: Rome glassmakers for the Fabrica di San Pietro. Journal of Cultural Heritage. 9. e93–e96. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026